Abstract
Deletion of 3p is one of the most frequent genetic alterations in many tumors, including esophageal squamous cell carcinoma (ESCC). In our recent study, deletion of 3p24 was frequently detected in ESCC and one candidate tumor suppressor gene (TSG), p300/CBP-associated factor (PCAF), was identified within the region. In this study, downregulation of PCAF was detected in 23/40 (57.5%) of primary ESCCs and 4/9 (44.4%) of the ESCC cell lines. A further study found that downregulation of PCAF was also associated with hypermethylation of the promoter region of PCAF gene. Methylation-specific PCR found that promoter methylation was detected in 28/40 (70%) of primary ESCCs and 5/9 (55.6%) of ESCC cell lines. In addition, the expression of PCAF could be reactivated in ESCC cell line KYSE510 after demethylation treatment with 5-aza-dC. Functional studies showed that PCAF was able to suppress tumorigenicity of ESCC cells both in vitro and in vivo, including foci formation, colony formation in soft agar and tumor formation in nude mice. Molecular study found that the tumor suppressive mechanism of PCAF was associated with its role in cell cycle arrest at the G1/S checkpoint by the downregulation of CDK2 and upregulation of p21waf1/Cip1, Smad4, Rb and p27Kip1. In conclusion, PCAF might be the target TSG responsible for the 3p24 deletion event, which has an important role in the development and progression of ESCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Atadja P, Wong H, Veillete C, Riabowol K . (1995). Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 217: 205–216.
Cao ZA, Daniel D, Hanahan D . (2002). Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer 2: 11.
Carnero A, Hannon GJ . (1998). The INK4 family of CDK inhibitors. Curr Top Microbiol Immunol 227: 43–55.
Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB . (2001). Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3: 667–674.
Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W et al. (1999). Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Ann N Y Acad Sci 880: 31–37.
de Jong JS, van Diest PJ, Michalides RJ, van der Valk P, Meijer CJ, Baak JP . (1998). Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Mol pathol 51: 30–34.
Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A et al. (2006). Cosmic 2005. Br J Cancer 94: 318–322.
Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G et al. (2007). Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 67: 10720–10726.
Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM . (2001). Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 61: 3806–3809.
Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC . (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98: 859–869.
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10–30.
Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M et al. (2003). Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63: 3724–3728.
Kwong D, Lam A, Guan X, Law S, Tai A, Wong J et al. (2004). Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 35: 309–316.
Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T . (2000). Regulation of E2F1 activity by acetylation. EMBO J 19: 662–671.
Offner FA . (2000). [Etiology, molecular biology and pathology of squamous cell carcinoma of the esophagus]. Pathologe 21: 349–357.
Ogasawara S, Maesawa C, Tamura G, Satodate R . (1995). Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 55: 891–894.
Ogryzko VV, Kotani T, Zhang X, Schiltz RL, Howard T, Yang XJ et al. (1998). Histone-like TAFs within the PCAF histone acetylase complex. Cell 94: 35–44.
Pack SD, Karkera JD, Zhuang Z, Pak ED, Balan KV, Hwu P et al. (1999). Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 25: 160–168.
Qin YR, Fu L, Sham PC, Kwong DL, Zhu CL, Chu KK et al. (2008). Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer 123: 826–830.
Schiltz RL, Nakatani Y . (2000). The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta 1470: M37–M53.
Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T . (1992). Characterization of 21 newly established esophageal cancer cell lines. Cancer 69: 277–284.
Tanaka H, Shibagaki I, Shimada Y, Wagata T, Imamura M, Ishizaki K . (1996). Chracterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Int J Cancer 65: 372–376.
Ullmannova V, Stockbauer P, Hradcova M, Soucek J, Haskovec C . (2003). Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk Res 27: 1115–1123.
Vogelstein B, Lane D, Levine AJ . (2000). Surfing the p53 network. Nature 408: 307–310.
Wang X, Pan L, Feng Y, Wang Y, Han Q, Han L et al. (2008). P300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 27: 1894–1904.
Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE et al. (2004). The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia 6: 187–194.
Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX et al. (2003). Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 107: 896–902.
Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y . (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319–324.
Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH et al. (2001). Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 92: 2769–2777.
Zhang C, Li K, Wei L, Li Z, Yu P, Teng L et al. (2007). p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma. J Clin Pathol 60: 1249–1253.
Zhao LY, Liu Y, Bertos NR, Yang XJ, Liao D . (2003). PCAF is a coactivator for p73-mediated transactivation. Oncogene 22: 8316–8329.
Acknowledgements
This work was supported by Research Grant Council Central Allocation (HKUST 2/06C), Sun Yat-Sen University ‘Hundred Talents Program’ (85000-3171311), a grant from the Major State Basic Research Program of China (2006CB910104) and a grant from the National Natural Science Foundation of China (30772475).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Zhu, C., Qin, YR., Xie, D. et al. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Oncogene 28, 2821–2828 (2009). https://doi.org/10.1038/onc.2009.137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.137
Keywords
This article is cited by
-
Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma
Oncogene (2019)
-
Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancer
Cell Death & Disease (2018)
-
Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma
Molecular and Cellular Biochemistry (2018)
-
A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage
Cell Death & Differentiation (2014)
-
Interplay among epigenetic alterations and crosstalk between genetic and epigenetic alterations in esophageal squamous cell carcinoma
Esophagus (2014)